The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Emtricitabine and Tenofovir Disoproxil Fumarate
EMTRICITABINE and TENOFOVIR Disoproxil Fumarate · EMTRICITABINE 200 mg/1; TENOFOVIR DISOPROXIL FUMARATE 300 mg/1 · Tablet · Oral · Golden State Medical Supply, Inc.
NDC 51407-0112-30 · 30 TABLET in 1 BOTTLE, PLASTIC · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for emtricitabine and tenofovir disoproxil fumarate (oral solid) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- Golden State Medical Supply Inc.United Statesrelabel · repack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA091055
- TE code
- AB
- Approval date
- Jan 13, 2021
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of EMTRICITABINE and TENOFOVIR Disoproxil Fumarate (Tablet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Golden State Medical Supply, Inc. | EMTRICITABINE 200 mg/1; TENOFOVIR DISOPROXIL FUMARATE 300 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Strides Pharma Inc. | EMTRICITABINE 200 mg/1; TENOFOVIR DISOPROXIL FUMARATE 300 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Strides Pharma Science Limited | EMTRICITABINE 200 mg/1; TENOFOVIR DISOPROXIL FUMARATE 300 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Emtricitabine and Tenofovir Disoproxil Fumarate — NDC 51407-0112-30," retrieved September 3, 2026, https://drugdashboards.com/drug/51407011230.
Free to cite with attribution — see how the data is put together.